MORGAN STANLEY

Holdings History for ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Symbol: ADCT on NYSE
Investment type: Equity / Common Shares, par value CHF 0.08 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$13,307,192	3,769,743	+100,676	+2.7%	$3.53	Q4 2025
30 Sep 2025	0%	+0%	$14,676,268	3,669,067	+623,494	+20%	$4.00	Q3 2025
30 Jun 2025	0%	+0%	$8,162,136	3,045,573	+25,988	+0.86%	$2.68	Q2 2025
31 Mar 2025	0%	-0%	$4,257,615	3,019,585	-936,587		$1.41	Q1 2025
31 Dec 2024	0%	+0%	$7,872,781	3,956,172	+915,378		$1.99	Q4 2024
30 Sep 2024	0%	+0%	$9,578,500	3,040,794	+75,565		$3.15	Q3 2024
30 Jun 2024	0%	+0%	$9,370,123	2,965,229	+244,834		$3.16	Q2 2024
31 Mar 2024	0%	+0%	$12,214,573	2,720,395	+1,938,458	+248%	$4.49	Q1 2024
31 Dec 2023	0%	+0%	$1,298,016	781,937	+117,910	+18%	$1.66	Q4 2023
30 Sep 2023	0%	+0%	$595,632	664,027	+11,249	+1.7%	$0.90	Q3 2023
30 Jun 2023	0%	+0%	$1,403,473	652,778	+214,829	+49%	$2.15	Q2 2023
31 Mar 2023	0%	+0%	$854,001	437,949	+87,176	+25%	$1.95	Q1 2023
31 Dec 2022	0%	+0%	$1,346,968	350,773	+67,761	+24%	$3.84	Q4 2022
30 Sep 2022	0%	+0%	$1,365,000	283,012	+77,462	+38%	$4.82	Q3 2022
30 Jun 2022	0%	+0%	$1,634,000	205,550	+119,686	+139%	$7.95	Q2 2022
31 Mar 2022	0%	+0%	$1,261,000	85,864	+15,024	+21%	$14.69	Q1 2022
31 Dec 2021	0%	-0%	$1,431,000	70,840	-14,015	-17%	$20.20	Q4 2021
30 Sep 2021	0%	-0%	$2,304,000	84,855	-164,652	-66%	$27.15	Q3 2021
30 Jun 2021	0%	+0%	$6,075,000	249,507	+45,280	+22%	$24.35	Q2 2021
31 Mar 2021	0%	+0%	$4,985,000	204,227	+94,416	+86%	$24.41	Q1 2021
31 Dec 2020	0%	+0%	$3,515,000	109,811	+99,320	+947%	$32.01	Q4 2020
30 Sep 2020	0%	-0%	$346,000	10,491	-2,094	-17%	$32.98	Q3 2020
30 Jun 2020	0%	+0%	$589,000	12,585	+12,585	NEW	$46.80	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.